The hazards of intermediate endpoints.
Beer
Tomasz M
TM
Ryan
Christopher W
CW
D000970:Antineoplastic Agents / Q000627:therapeutic use; D002986:Clinical Trials as Topic / Q000379:methods*; D018572:Disease-Free Survival; D023381:Endpoint Determination; D006801:Humans; D008297:Male; D011471:Prostatic Neoplasms / Q000188:drug therapy / Q000401:mortality*
D000970:Antineoplastic Agents